Finerenone Achieves 25 Percent Greater Albuminuria Reduction in Type 1 Diabetes and CKD: FINE-ONE Study Finds Aashi verma25 March 2026 8:00 AM ISTFinerenone achieves a 25% greater reduction in albuminuria compared to placebo in adults with type 1 diabetes and chronic kidney disease, a recent...
Inhaled Treprostinil Slows Disease Progression in idiopathic pulmonary fibrosis: NEJM Jacinthlyn Sylvia23 March 2026 10:00 PM ISTA new study published in The New England Journal of Medicine revealed that in idiopathic pulmonary fibrosis (IPF) inhaled treprostinil slowed the...
Left Atrial Appendage Closure Not Noninferior to Medical Therapy in High-Risk Atrial Fibrillation: Study Dr Riya Dave21 March 2026 11:30 AM ISTResearchers have discovered in a new research that among patients with atrial fibrillation at high risk for both stroke and bleeding, left atrial...
Prehospital Whole Blood Transfusion Offers No Survival Benefit versus Component Therapy in Traumatic Hemorrhage: SWiFT Trial Medha Baranwal21 March 2026 9:15 AM ISTUK: The SWiFT trial has found that prehospital transfusion of whole blood did not improve survival or reduce massive transfusion rates compared to...
COBRRA Trial: Apixaban Shows Lower Bleeding Risk Than Rivaroxaban in Acute VTE Jacinthlyn Sylvia18 March 2026 9:15 AM ISTThe COBRRA randomized trial that compared direct oral anticoagulants (DOACs) for acute venous thromboembolism (VTE), and found apixaban to be...
CTNS-RD-04 Gene Therapy Lowers Cystine Levels Safely: JAMA Dr Riya Dave16 March 2026 8:30 PM ISTCTNS-RD-04, an ex vivo gene therapy for cystinosis, showed reduced white-cell cystine levels and an acceptable safety profile in a small phase 1-2...
Finerenone Significantly Reduces Albuminuria in Type 1 Diabetes CKD, suggests study Dr Riya Dave9 March 2026 11:00 AM ISTFinerenone has been shown to reduce urinary albumin excretion in adults with type 1 diabetes and chronic kidney disease (CKD) in a randomized clinical...
Zorevunersen Shows Promise as Disease-Modifying Therapy in Dravet Syndrome: Study Dr Riya Dave8 March 2026 8:00 PM ISTA new form of antisense therapy, zorevunersen, has established the safety profile and clinical efficacy of the treatment of Dravet syndrome, according...
Study Observed No Clear Benefit of Tecovirimat in Clade II Mpox Patients: NEJM Jacinthlyn Sylvia4 March 2026 8:30 PM ISTA new study published in The New England Journal of Medicine revealed that the antiviral drug tecovirimat did not significantly improve recovery...
Fremanezumab Reduces Migraine Days in Children and Adolescents: NEJM Jacinthlyn Sylvia27 Feb 2026 9:30 PM ISTA new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more than a placebo in...
Sterile Wolbachia-Infected Mosquitoes Reduce Dengue Risk by Over 70 percent: NEJM Dr Riya Dave13 Feb 2026 9:00 PM ISTResearchers have found in a new study that releasing sterile Wolbachia-infected male Aedes aegypti mosquitoes significantly reduced mosquito...
Enlicitide, an oral PCSK9 inhibitor, significantly lowers LDL cholesterol levels, claims research Jacinthlyn Sylvia11 Feb 2026 10:00 AM ISTA new study published in The New England Journal of Medicine showed that at 24 weeks, therapy with the oral PCSK9 inhibitor enlicitide resulted in...
